BIO Raps “Questionable Data” in New Studies on IRA Impact on Biotech R&D

Ensuring that laws such as the Inflation Reduction Act (IRA) do not have unexpected consequences or diminish patient-centric innovation requires a clear-eyed view of the way that legislation operates in the real world, the Biotechnology Innovation Organization (BIO) said in response to two studies conducted by Bentley University.
Source: Drug Industry Daily